Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe
Author:
Publisher
Wiley
Subject
Neurology (clinical),Neurology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1331.2009.02753.x/fullpdf
Reference17 articles.
1. Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study;Petrovitch;Neurology,2001
2. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease;McKhann;Neurology,1984
3. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria;Dubois;Lancet Neurol,2007
4. Serum amyloid beta peptides in patients with dementia and age-matched non-demented controls as detected by surface-enhanced laser desorption ionisation-time of flight mass spectrometry (SELDI-TOF MS);Frankfort;Curr Clin Pharmacol,2008
5. CSF and MRI markers independently contribute to the diagnosis of Alzheimer’s disease;Schoonenboom;Neurobiol Aging,2008
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Subclinical memory impairment in unaffected siblings of patients with dementia;The Clinical Neuropsychologist;2023-03-03
2. 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework;European Journal of Nuclear Medicine and Molecular Imaging;2021-03-05
3. Comparison of Two Analytical Platforms in Cerebrospinal Fluid Biomarkers for the Classification of Alzheimer’s Disease Spectrum with Amyloid PET Imaging;Journal of Alzheimer's Disease;2020-06-02
4. The standardization of cerebrospinal fluid markers and neuropathological diagnoses brings to light the frequent complexity of concomitant pathology in Alzheimer's disease: The next challenge for biochemical markers?;Clinical Biochemistry;2019-10
5. Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS;Clinical Biochemistry;2019-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3